Journal article
Subcellular targeting of theranostic radionuclides
- Abstract:
-
The last decade has seen rapid growth in the use of theranostic radionuclides for the treatment and imaging of a wide range of cancers. Radionuclide therapy and imaging rely on a radiolabeled vector to specifically target cancer cells. Radionuclides that emit β particles have thus far dominated the field of targeted radionuclide therapy (TRT), mainly because the longer range (μm–mm track length) of these particles offsets the heterogeneous expression of the molecular target. Shorter range (nm...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Bibliographic Details
- Publisher:
- Frontiers Media Publisher's website
- Journal:
- Frontiers in Pharmacology Journal website
- Volume:
- 9
- Article number:
- 996
- Publication date:
- 2018-09-04
- Acceptance date:
- 2018-08-13
- DOI:
- ISSN:
-
1663-9812
Item Description
- Keywords:
- Pubs id:
-
pubs:910901
- UUID:
-
uuid:3aa17506-05c2-4bc8-9ed5-f99add3c74ac
- Local pid:
- pubs:910901
- Source identifiers:
-
910901
- Deposit date:
- 2018-08-29
Terms of use
- Copyright holder:
- Bavelaar et al
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 Bavelaar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record